Pneumonia News and Research

Latest Pneumonia News and Research

Study suggests that existing HIV drug could be a potential therapy for Staph infections

A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year.

15 Dec 2012

Meridian completes beta trials for two new illumigene molecular amplification tests

Meridian Bioscience, Inc. today announced that it has successfully completed beta trials for two new illumigene molecular amplification tests.

14 Dec 2012

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

Inexpensive, locally-produced ceramic cookstoves may produce less smoke than traditional indoor 3-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya.

13 Dec 2012

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Inspiration Biopharmaceuticals, Inc. (Inspiration) announced interim clinical results for the company's two lead product candidates, an intravenous recombinant porcine FVIII (OBI-1) in the treatment of serious bleeds in acquired hemophilia A (AHA) and an intravenous recombinant FIX (IB1001) for the treatment and prevention of bleeding in children less than 12 years of age with hemophilia B.

13 Dec 2012

Benzodiazepines associated with fatal pneumonia

Benzodiazepines are associated with an increased risk for developing pneumonia, as well as an increased risk for dying from pneumonia, research shows.

12 Dec 2012

Ultrasonography effective for diagnosing childhood pneumonia

Point-of-care ultrasound scanning can be used to diagnose pneumonia accurately in children and young people, show study findings.

11 Dec 2012

New coronavirus can infect cells from humans and bats alike

The SARS epidemic of 2002-2003 was short-lived, but a novel type of human coronavirus that is alarming public health authorities can infect cells from humans and bats alike, a fact that could make the animals a continuing source of infection, according to a study to be published in in mBio-, the online open-access journal of the American Society for Microbiology, on December 11.

11 Dec 2012

Pomalidomide safe and effective in treating multiple myeloma

A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount Sinai School of Medicine researchers at the American Society of Hematology (ASH) Annual Meeting. The meeting is taking place December 8-11, 2012 in Atlanta.

11 Dec 2012

Combination of ibrutinib and rituximab shows promise against chronic lymphocytic leukemia

A two-prong approach combining ibrutinib and rituximab (Rituxin) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.

11 Dec 2012

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene International Sàrl today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated acute myeloid leukemia (AML) were presented at the American Society of Hematology annual meeting in Atlanta, GA.

11 Dec 2012

Immune dysfunction pinpointed in developmental disorder

Children with neurodevelopmental abnormalities resulting from duplication of the methyl-CpG binding protein 2 gene also have impaired T-helper-cell 1 responses, research shows.

10 Dec 2012

Patients with sickle cell disease rely more on emergency room

Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.

10 Dec 2012

Nuron Biotech announces acquisition of Meningitec from Pfizer

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.

10 Dec 2012

Angiocidin reduces acute myeloid leukemia cells in vivo by almost two-thirds in pre-clinical studies

Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments.

10 Dec 2012

Pay for performance may have reduced UK mortality rates

The introduction in 2008 of a US-based “pay-for-performance” scheme into National Health Service hospitals in the northwest of the UK resulted in a significant decrease in mortality rates, particularly for pneumonia, study findings show.

7 Dec 2012

Health workers face 'severe logistical challenges' to vaccinating Maasai tribes in Tanzania

Chris Endean of the GAVI Alliance writes ahead of the GAVI Partners Forum in a CNN opinion piece about efforts to vaccinate members of the Maasai tribes in Tanzania's Arusha National Park. Noting Maasai tribes are "constantly on the move searching for water and fresh pasture for their cattle," he describes "severe logistical challenges" health workers face when trying to reach their patients and notes."

7 Dec 2012

FDA designates two of Cubist’s Phase 3 antibiotic candidates

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company's Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam) and CB-315, as Qualified Infectious Disease Products (QIDP).

6 Dec 2012

WHO assists Middle East authorities with coronavirus investigation

The World Health Organization has sent a team to Jordan at the request of the country’s Ministry of Health to help investigate the emergence of a novel coronavirus that resulted in the deaths of two people earlier this year, and to assist with further epidemiologic surveillance.

5 Dec 2012

Software to curb hospital readmissions?

Stung by a multimillion-dollar penalty for failing to meet new patient readmissions standards set by Medicare, UMass Memorial Health Care is using transaction analytics software to reduce frequent and costly readmissions for patients with heart attacks, heart failure and pneumonia.

5 Dec 2012

Swedish Medical Center/First Hill named among Leapfrog Group's 2012 Top Hospitals

The Leapfrog Group's annual class of 'Top Hospitals' – just 89 from a field of nearly 1,200 – will be announced today in Baltimore, Md., and includes Swedish Medical Center/First Hill for the third year in a row. The announcement will take place at Leapfrog's Annual Meeting.

4 Dec 2012

Pneumonia News and Research

Latest Pneumonia News and Research

Study suggests that existing HIV drug could be a potential therapy for Staph infections

Meridian completes beta trials for two new illumigene molecular amplification tests

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

Interim results from Inspiration’s OBI-1 and IB1001 hemophilia clinical study

Benzodiazepines associated with fatal pneumonia

Ultrasonography effective for diagnosing childhood pneumonia

New coronavirus can infect cells from humans and bats alike

Pomalidomide safe and effective in treating multiple myeloma

Combination of ibrutinib and rituximab shows promise against chronic lymphocytic leukemia

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Immune dysfunction pinpointed in developmental disorder

Patients with sickle cell disease rely more on emergency room

Nuron Biotech announces acquisition of Meningitec from Pfizer

Angiocidin reduces acute myeloid leukemia cells in vivo by almost two-thirds in pre-clinical studies

Pay for performance may have reduced UK mortality rates

Health workers face 'severe logistical challenges' to vaccinating Maasai tribes in Tanzania

FDA designates two of Cubist’s Phase 3 antibiotic candidates

WHO assists Middle East authorities with coronavirus investigation

Software to curb hospital readmissions?

Swedish Medical Center/First Hill named among Leapfrog Group's 2012 Top Hospitals

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pneumonia News and Research

Latest Pneumonia News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in